Carol Karp's most recent trade in Prothena Corporation plc was a trade of 107,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Prothena Corporation plc | Carol D. Karp | Chief Regulatory Officer | 05 Mar 2025 | 107,500 | 107,500 | - | - | Stock Option (Right to Buy) | ||
Prothena Corporation plc | D. Karp Carol | Chief Regulatory Officer | 27 Feb 2024 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 02 Aug 2023 | 5,000 | 5,000 (0%) | 0% | 12.2 | 60,750 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 02 Aug 2023 | 5,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 02 Aug 2023 | 4,672 | 328 (0%) | 0% | 66.9 | 312,784 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 02 Aug 2023 | 328 | 0 (0%) | 0% | 68.0 | 22,288 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 05 Jul 2023 | 5,000 | 5,000 (0%) | 0% | 12.2 | 60,750 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 05 Jul 2023 | 5,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 05 Jul 2023 | 3,966 | 1,034 (0%) | 0% | 68.0 | 269,609 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 05 Jul 2023 | 1,034 | 0 (0%) | 0% | 68.7 | 71,027 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 07 Jun 2023 | 15,000 | 20,000 (0%) | 0% | 13.5 | 202,950 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 07 Jun 2023 | 15,000 | 35,000 | - | - | Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 07 Jun 2023 | 12,782 | 4,172 (0%) | 0% | 71.0 | 907,495 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 07 Jun 2023 | 5,000 | 5,000 (0%) | 0% | 12.2 | 60,750 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 07 Jun 2023 | 5,000 | 65,000 | - | - | Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 07 Jun 2023 | 3,811 | 361 (0%) | 0% | 72.0 | 274,271 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 07 Jun 2023 | 3,046 | 16,954 (0%) | 0% | 69.9 | 212,916 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 07 Jun 2023 | 361 | 0 (0%) | 0% | 72.9 | 26,328 | Ordinary Shares, par value $0.01 per share | |
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 02 Mar 2023 | 48,000 | 48,000 | - | - | Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 25 Feb 2021 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 12 Feb 2021 | 100,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 12 Feb 2021 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 12 Feb 2021 | 51,282 | 51,282 | - | - | Employee Stock Option (Right to Buy) | ||
Prothena Corporation plc | Carol Karp | Chief Regulatory Officer | 12 Feb 2021 | 45,112 | 45,112 | - | - | Employee Stock Option (Right to Buy) |